PortfoliosLab logoPortfoliosLab logo

Global X Genomics & Biotechnology UCITS ETF (GNOM.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with GNOM.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to GNOM.L

GNOM.L charges 0.50% annually. There are 28 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.


Best Risk-Adjusted Alternatives to GNOM.L

GNOM.L has a PortfoliosLab risk / return rank of 77. There are 6 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 91.


Top Performing GNOM.L Alternatives (YTD)

GNOM.L is at 22.10% YTD. No ETFs in the Health & Biotech Equities category have higher YTD returns; the top-performing alternatives shown here go as high as 21.62%.


Lowest Volatility Alternatives to GNOM.L

GNOM.L has 29.87% 1-year volatility. There are 32 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 14.26%.


Lowest Drawdown Alternatives to GNOM.L

GNOM.L has a 1-year max drawdown of -18.91%. There are 30 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.


Other ETFs from Global X

The 10 most viewed Global X ETFs shown here include URNU.L, SILG.L, QYLP.L and span 8 categories. AUM among these funds goes as high as $674M.


Compare GNOM.L with Any Fund or Stock

Compare GNOM.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair GNOM.L with funds that move differently

Global X Genomics & Biotechnology UCITS ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to GNOM.L.

Explore GNOM.L Diversifiers